甲磺酸伊马替尼治疗后出现的致命性肝坏死。 - Suppr

Fatal hepatic necrosis following imatinib mesylate therapy.

作者信息

Lin Nancy U, Sarantopoulos Stefanie, Stone James R, Galinsky Ilene, Stone Richard M, Deangelo Daniel J, Soiffer Robert J

出版信息

Blood. 2003 Nov 1;102(9):3455-6. doi: 10.1182/blood-2003-07-2323.

DOI:10.1182/blood-2003-07-2323

PMID:14568907

Abstract

摘要

相似文献

Fatal hepatic necrosis following imatinib mesylate therapy.甲磺酸伊马替尼治疗后出现的致命性肝坏死。

Blood. 2003 Nov 1;102(9):3455-6. doi: 10.1182/blood-2003-07-2323.

Imatinib and ruxolitinib association: first experience in two patients.伊马替尼与芦可替尼联合应用：两例患者的首次经验

Haematologica. 2014 Jun;99(6):e76-7. doi: 10.3324/haematol.2013.102525. Epub 2014 Mar 14.

Polycythemia vera responds to imatinib mesylate.真性红细胞增多症对甲磺酸伊马替尼有反应。

Am J Med Sci. 2003 Mar;325(3):149-52. doi: 10.1097/00000441-200303000-00007.

[Imatinib mesylate-induced acute cytolytic hepatitis].甲磺酸伊马替尼诱导的急性细胞溶解性肝炎

Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):918-9. doi: 10.1016/s0399-8320(04)95160-3.

Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia.慢性粒细胞白血病中早期甲磺酸伊马替尼诱导的肝毒性

Acta Haematol. 2007;118(4):205-8. doi: 10.1159/000111092. Epub 2007 Nov 15.

Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management.甲磺酸伊马替尼治疗慢性粒细胞白血病所致严重肝损伤及泼尼松龙对其的治疗效果。

Int J Hematol. 2005 Nov;82(4):343-6. doi: 10.1532/IJH97.05034.

Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.甲磺酸伊马替尼所致肝损伤在一名未经治疗的慢性期慢性粒细胞白血病患者中的成功管理。

Leuk Lymphoma. 2006 Jul;47(7):1427-30. doi: 10.1080/10428190600593877.

Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate.聚乙二醇干扰素α或甲磺酸伊马替尼治疗真性红细胞增多症的最新进展。

Curr Hematol Malig Rep. 2007 Feb;2(1):43-6. doi: 10.1007/s11899-007-0006-2.

Phase II open label trial of imatinib in polycythemia rubra vera.伊马替尼治疗真性红细胞增多症的II期开放标签试验。

Int J Hematol. 2008 Dec;88(5):489-494. doi: 10.1007/s12185-008-0193-1. Epub 2008 Nov 15.

Treatment of polycythemia vera with recombinant interferon alpha (rIFNalpha) or imatinib mesylate.用重组干扰素α（rIFNα）或甲磺酸伊马替尼治疗真性红细胞增多症。

Curr Hematol Rep. 2005 May;4(3):235-7.

引用本文的文献

Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.慢性粒细胞白血病、磺胺过敏和类风湿关节炎患者急性伊马替尼诱导性肝炎病例报告

Cureus. 2018 Aug 13;10(8):e3136. doi: 10.7759/cureus.3136.

Imatinib-induced fulminant liver failure in chronic myeloid leukemia: role of liver transplant and second-generation tyrosine kinase inhibitors: a case report.伊马替尼致慢性髓性白血病暴发性肝衰竭：肝移植及第二代酪氨酸激酶抑制剂的作用：一例报告

J Med Case Rep. 2018 Mar 10;12(1):63. doi: 10.1186/s13256-018-1588-0.

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.欧洲白血病网关于慢性髓性白血病治疗管理及不良事件避免的建议

Leukemia. 2016 Aug;30(8):1648-71. doi: 10.1038/leu.2016.104. Epub 2016 Apr 28.

Kinase inhibitors and monoclonal antibodies in oncology: clinical implications.激酶抑制剂和单克隆抗体在肿瘤学中的临床应用。

Nat Rev Clin Oncol. 2016 Apr;13(4):209-27. doi: 10.1038/nrclinonc.2015.213. Epub 2015 Dec 31.

Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management.全身治疗引起的胃肠道毒性：发生率、临床表现及管理

Ann Gastroenterol. 2012;25(2):106-118.

Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia.两名慢性期慢性髓性白血病患者在接受羟基脲治疗后紧接着使用尼罗替尼治疗后发生肿瘤溶解综合征。

Int J Hematol. 2013 Aug;98(2):243-6. doi: 10.1007/s12185-013-1356-2. Epub 2013 May 7.

Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.酪氨酸激酶抑制剂的肝毒性：临床与监管视角。

Drug Saf. 2013 Jul;36(7):491-503. doi: 10.1007/s40264-013-0048-4.

Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.伊马替尼对慢性期慢性髓性白血病患者的主要长期不良反应。

Biologics. 2010 Dec 2;4:315-23. doi: 10.2147/BTT.S5775.

Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors.甲磺酸伊马替尼致胃肠间质瘤患者急性肝衰竭

Med Oncol. 2010 Sep;27(3):768-73. doi: 10.1007/s12032-009-9284-y. Epub 2009 Aug 7.

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).治疗慢性髓性白血病的选择：聚焦伊马替尼（格列卫，商品名）。

Ther Clin Risk Manag. 2008 Feb;4(1):163-87.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Fatal hepatic necrosis following imatinib mesylate therapy.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献